T-cell engaging bsAbs Drugs Market
1 T-cell engaging bsAbs Drugs Market Overview
1.1 Product Overview and Scope of T-cell engaging bsAbs Drugs
1.2 T-cell engaging bsAbs Drugs Segment by Type
1.2.1 Global T-cell engaging bsAbs Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Blincyto
1.2.3 Kimmtrak
1.3 T-cell engaging bsAbs Drugs Segment by Application
1.3.1 Global T-cell engaging bsAbs Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hematological Cancers
1.3.3 Solid Tumors
1.4 Global T-cell engaging bsAbs Drugs Market Size Estimates and Forecasts
1.4.1 Global T-cell engaging bsAbs Drugs Revenue 2017-2028
1.4.2 Global T-cell engaging bsAbs Drugs Sales 2017-2028
1.4.3 T-cell engaging bsAbs Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 T-cell engaging bsAbs Drugs Market Competition by Manufacturers
2.1 Global T-cell engaging bsAbs Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global T-cell engaging bsAbs Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global T-cell engaging bsAbs Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers T-cell engaging bsAbs Drugs Manufacturing Sites, Area Served, Product Type
2.5 T-cell engaging bsAbs Drugs Market Competitive Situation and Trends
2.5.1 T-cell engaging bsAbs Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest T-cell engaging bsAbs Drugs Players Market Share by Revenue
2.5.3 Global T-cell engaging bsAbs Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 T-cell engaging bsAbs Drugs Retrospective Market Scenario by Region
3.1 Global T-cell engaging bsAbs Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global T-cell engaging bsAbs Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America T-cell engaging bsAbs Drugs Market Facts & Figures by Country
3.3.1 North America T-cell engaging bsAbs Drugs Sales by Country
3.3.2 North America T-cell engaging bsAbs Drugs Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe T-cell engaging bsAbs Drugs Market Facts & Figures by Country
3.4.1 Europe T-cell engaging bsAbs Drugs Sales by Country
3.4.2 Europe T-cell engaging bsAbs Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific T-cell engaging bsAbs Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific T-cell engaging bsAbs Drugs Sales by Region
3.5.2 Asia Pacific T-cell engaging bsAbs Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America T-cell engaging bsAbs Drugs Market Facts & Figures by Country
3.6.1 Latin America T-cell engaging bsAbs Drugs Sales by Country
3.6.2 Latin America T-cell engaging bsAbs Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa T-cell engaging bsAbs Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa T-cell engaging bsAbs Drugs Sales by Country
3.7.2 Middle East and Africa T-cell engaging bsAbs Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global T-cell engaging bsAbs Drugs Historic Market Analysis by Type
4.1 Global T-cell engaging bsAbs Drugs Sales Market Share by Type (2017-2022)
4.2 Global T-cell engaging bsAbs Drugs Revenue Market Share by Type (2017-2022)
4.3 Global T-cell engaging bsAbs Drugs Price by Type (2017-2022)
5 Global T-cell engaging bsAbs Drugs Historic Market Analysis by Application
5.1 Global T-cell engaging bsAbs Drugs Sales Market Share by Application (2017-2022)
5.2 Global T-cell engaging bsAbs Drugs Revenue Market Share by Application (2017-2022)
5.3 Global T-cell engaging bsAbs Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen T-cell engaging bsAbs Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Amgen T-cell engaging bsAbs Drugs Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Immunocore
6.2.1 Immunocore Corporation Information
6.2.2 Immunocore Description and Business Overview
6.2.3 Immunocore T-cell engaging bsAbs Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Immunocore T-cell engaging bsAbs Drugs Product Portfolio
6.2.5 Immunocore Recent Developments/Updates
7 T-cell engaging bsAbs Drugs Manufacturing Cost Analysis
7.1 T-cell engaging bsAbs Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of T-cell engaging bsAbs Drugs
7.4 T-cell engaging bsAbs Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 T-cell engaging bsAbs Drugs Distributors List
8.3 T-cell engaging bsAbs Drugs Customers
9 T-cell engaging bsAbs Drugs Market Dynamics
9.1 T-cell engaging bsAbs Drugs Industry Trends
9.2 T-cell engaging bsAbs Drugs Market Drivers
9.3 T-cell engaging bsAbs Drugs Market Challenges
9.4 T-cell engaging bsAbs Drugs Market Restraints
10 Global Market Forecast
10.1 T-cell engaging bsAbs Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of T-cell engaging bsAbs Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of T-cell engaging bsAbs Drugs by Type (2023-2028)
10.2 T-cell engaging bsAbs Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of T-cell engaging bsAbs Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of T-cell engaging bsAbs Drugs by Application (2023-2028)
10.3 T-cell engaging bsAbs Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of T-cell engaging bsAbs Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of T-cell engaging bsAbs Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global T-cell engaging bsAbs Drugs Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global T-cell engaging bsAbs Drugs Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global T-cell engaging bsAbs Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global T-cell engaging bsAbs Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global T-cell engaging bsAbs Drugs Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global T-cell engaging bsAbs Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global T-cell engaging bsAbs Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global T-cell engaging bsAbs Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market T-cell engaging bsAbs Drugs Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers T-cell engaging bsAbs Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers T-cell engaging bsAbs Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global T-cell engaging bsAbs Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-cell engaging bsAbs Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global T-cell engaging bsAbs Drugs Sales by Region (2017-2022) & (Units)
Table 16. Global T-cell engaging bsAbs Drugs Sales Market Share by Region (2017-2022)
Table 17. Global T-cell engaging bsAbs Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global T-cell engaging bsAbs Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America T-cell engaging bsAbs Drugs Sales by Country (2017-2022) & (Units)
Table 20. North America T-cell engaging bsAbs Drugs Sales Market Share by Country (2017-2022)
Table 21. North America T-cell engaging bsAbs Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America T-cell engaging bsAbs Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe T-cell engaging bsAbs Drugs Sales by Country (2017-2022) & (Units)
Table 24. Europe T-cell engaging bsAbs Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe T-cell engaging bsAbs Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe T-cell engaging bsAbs Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific T-cell engaging bsAbs Drugs Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific T-cell engaging bsAbs Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific T-cell engaging bsAbs Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific T-cell engaging bsAbs Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America T-cell engaging bsAbs Drugs Sales by Country (2017-2022) & (Units)
Table 32. Latin America T-cell engaging bsAbs Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America T-cell engaging bsAbs Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America T-cell engaging bsAbs Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa T-cell engaging bsAbs Drugs Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa T-cell engaging bsAbs Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa T-cell engaging bsAbs Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa T-cell engaging bsAbs Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global T-cell engaging bsAbs Drugs Sales by Type (2017-2022) & (Units)
Table 40. Global T-cell engaging bsAbs Drugs Sales Market Share by Type (2017-2022)
Table 41. Global T-cell engaging bsAbs Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global T-cell engaging bsAbs Drugs Revenue Share by Type (2017-2022)
Table 43. Global T-cell engaging bsAbs Drugs Price by Type (2017-2022) & (US$/Unit)
Table 44. Global T-cell engaging bsAbs Drugs Sales (Units) by Application (2017-2022)
Table 45. Global T-cell engaging bsAbs Drugs Sales Market Share by Application (2017-2022)
Table 46. Global T-cell engaging bsAbs Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global T-cell engaging bsAbs Drugs Revenue Share by Application (2017-2022)
Table 48. Global T-cell engaging bsAbs Drugs Price by Application (2017-2022) & (US$/Unit)
Table 49. Amgen Corporation Information
Table 50. Amgen Description and Business Overview
Table 51. Amgen T-cell engaging bsAbs Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Amgen T-cell engaging bsAbs Drugs Product
Table 53. Amgen Recent Developments/Updates
Table 54. Immunocore Corporation Information
Table 55. Immunocore Description and Business Overview
Table 56. Immunocore T-cell engaging bsAbs Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Immunocore T-cell engaging bsAbs Drugs Product
Table 58. Immunocore Recent Developments/Updates
Table 59. Production Base and Market Concentration Rate of Raw Material
Table 60. Key Suppliers of Raw Materials
Table 61. T-cell engaging bsAbs Drugs Distributors List
Table 62. T-cell engaging bsAbs Drugs Customers List
Table 63. T-cell engaging bsAbs Drugs Market Trends
Table 64. T-cell engaging bsAbs Drugs Market Drivers
Table 65. T-cell engaging bsAbs Drugs Market Challenges
Table 66. T-cell engaging bsAbs Drugs Market Restraints
Table 67. Global T-cell engaging bsAbs Drugs Sales Forecast by Type (2023-2028) & (Units)
Table 68. Global T-cell engaging bsAbs Drugs Sales Market Share Forecast by Type (2023-2028)
Table 69. Global T-cell engaging bsAbs Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 70. Global T-cell engaging bsAbs Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 71. Global T-cell engaging bsAbs Drugs Sales Forecast by Application (2023-2028) & (Units)
Table 72. Global T-cell engaging bsAbs Drugs Sales Market Share Forecast by Application (2023-2028)
Table 73. Global T-cell engaging bsAbs Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 74. Global T-cell engaging bsAbs Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 75. Global T-cell engaging bsAbs Drugs Sales Forecast by Region (2023-2028) & (Units)
Table 76. Global T-cell engaging bsAbs Drugs Sales Market Share Forecast by Region (2023-2028)
Table 77. Global T-cell engaging bsAbs Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 78. Global T-cell engaging bsAbs Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of T-cell engaging bsAbs Drugs
Figure 2. Global T-cell engaging bsAbs Drugs Market Share by Type in 2021 & 2028
Figure 3. Blincyto Product Picture
Figure 4. Kimmtrak Product Picture
Figure 5. Global T-cell engaging bsAbs Drugs Market Share by Application in 2021 & 2028
Figure 6. Hematological Cancers
Figure 7. Solid Tumors
Figure 8. Global T-cell engaging bsAbs Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global T-cell engaging bsAbs Drugs Market Size (2017-2028) & (US$ Million)
Figure 10. Global T-cell engaging bsAbs Drugs Sales (2017-2028) & (Units)
Figure 11. T-cell engaging bsAbs Drugs Sales Share by Manufacturers in 2021
Figure 12. Global T-cell engaging bsAbs Drugs Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest T-cell engaging bsAbs Drugs Players: Market Share by Revenue in 2021
Figure 14. T-cell engaging bsAbs Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global T-cell engaging bsAbs Drugs Sales Market Share by Region (2017-2022)
Figure 16. Global T-cell engaging bsAbs Drugs Sales Market Share by Region in 2021
Figure 17. Global T-cell engaging bsAbs Drugs Revenue Market Share by Region (2017-2022)
Figure 18. Global T-cell engaging bsAbs Drugs Revenue Market Share by Region in 2021
Figure 19. United States T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Turkey T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Saudi Arabia T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. UAE T-cell engaging bsAbs Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Sales Market Share of T-cell engaging bsAbs Drugs by Type (2017-2022)
Figure 42. Manufacturing Cost Structure of T-cell engaging bsAbs Drugs
Figure 43. Manufacturing Process Analysis of T-cell engaging bsAbs Drugs
Figure 44. T-cell engaging bsAbs Drugs Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Industry Market Size
